These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Entropy as a Driver of Selectivity for Inhibitor Binding to Histone Deacetylase 6. Porter NJ; Wagner FF; Christianson DW Biochemistry; 2018 Jul; 57(26):3916-3924. PubMed ID: 29775292 [TBL] [Abstract][Full Text] [Related]
43. Members of the histone deacetylase superfamily differ in substrate specificity towards small synthetic substrates. Riester D; Wegener D; Hildmann C; Schwienhorst A Biochem Biophys Res Commun; 2004 Nov; 324(3):1116-23. PubMed ID: 15485670 [TBL] [Abstract][Full Text] [Related]
44. Toward selective histone deacetylase inhibitor design: homology modeling, docking studies, and molecular dynamics simulations of human class I histone deacetylases. Wang DF; Helquist P; Wiech NL; Wiest O J Med Chem; 2005 Nov; 48(22):6936-47. PubMed ID: 16250652 [TBL] [Abstract][Full Text] [Related]
46. A proton-shuttle reaction mechanism for histone deacetylase 8 and the catalytic role of metal ions. Wu R; Wang S; Zhou N; Cao Z; Zhang Y J Am Chem Soc; 2010 Jul; 132(27):9471-9. PubMed ID: 20568751 [TBL] [Abstract][Full Text] [Related]
47. X-ray Crystallographic Snapshots of Substrate Binding in the Active Site of Histone Deacetylase 10. Herbst-Gervasoni CJ; Christianson DW Biochemistry; 2021 Feb; 60(4):303-313. PubMed ID: 33449614 [TBL] [Abstract][Full Text] [Related]
48. Cloning and characterization of a novel human histone deacetylase, HDAC8. Buggy JJ; Sideris ML; Mak P; Lorimer DD; McIntosh B; Clark JM Biochem J; 2000 Aug; 350 Pt 1(Pt 1):199-205. PubMed ID: 10926844 [TBL] [Abstract][Full Text] [Related]
49. Potent non-hydroxamate inhibitors of histone deacetylase-8: Role and scope of an isoindolin-2-yl linker with an α-amino amide as the zinc-binding unit. Greenwood SOR; Chan AWE; Hansen DF; Marson CM Bioorg Med Chem Lett; 2020 Mar; 30(5):126926. PubMed ID: 31952961 [TBL] [Abstract][Full Text] [Related]
50. Activation and inhibition of histone deacetylase 8 by monovalent cations. Gantt SL; Joseph CG; Fierke CA J Biol Chem; 2010 Feb; 285(9):6036-43. PubMed ID: 20029090 [TBL] [Abstract][Full Text] [Related]
51. X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design. Grams F; Reinemer P; Powers JC; Kleine T; Pieper M; Tschesche H; Huber R; Bode W Eur J Biochem; 1995 Mar; 228(3):830-41. PubMed ID: 7737183 [TBL] [Abstract][Full Text] [Related]
52. Human HDAC7 harbors a class IIa histone deacetylase-specific zinc binding motif and cryptic deacetylase activity. Schuetz A; Min J; Allali-Hassani A; Schapira M; Shuen M; Loppnau P; Mazitschek R; Kwiatkowski NP; Lewis TA; Maglathin RL; McLean TH; Bochkarev A; Plotnikov AN; Vedadi M; Arrowsmith CH J Biol Chem; 2008 Apr; 283(17):11355-63. PubMed ID: 18285338 [TBL] [Abstract][Full Text] [Related]
53. Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A. Codd R; Braich N; Liu J; Soe CZ; Pakchung AA Int J Biochem Cell Biol; 2009 Apr; 41(4):736-9. PubMed ID: 18725319 [TBL] [Abstract][Full Text] [Related]
54. Design, synthesis, and biological activity of NCC149 derivatives as histone deacetylase 8-selective inhibitors. Suzuki T; Muto N; Bando M; Itoh Y; Masaki A; Ri M; Ota Y; Nakagawa H; Iida S; Shirahige K; Miyata N ChemMedChem; 2014 Mar; 9(3):657-64. PubMed ID: 24403121 [TBL] [Abstract][Full Text] [Related]
55. Binding mode analysis of 3-(4-benzoyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamide: a new synthetic histone deacetylase inhibitor inducing histone hyperacetylation, growth inhibition, and terminal cell differentiation. Mai A; Massa S; Ragno R; Esposito M; Sbardella G; Nocca G; Scatena R; Jesacher F; Loidl P; Brosch G J Med Chem; 2002 Apr; 45(9):1778-84. PubMed ID: 11960489 [TBL] [Abstract][Full Text] [Related]
56. Negative regulation of histone deacetylase 8 activity by cyclic AMP-dependent protein kinase A. Lee H; Rezai-Zadeh N; Seto E Mol Cell Biol; 2004 Jan; 24(2):765-73. PubMed ID: 14701748 [TBL] [Abstract][Full Text] [Related]
57. Discovery of the first histone deacetylase 6/8 dual inhibitors. Olson DE; Wagner FF; Kaya T; Gale JP; Aidoud N; Davoine EL; Lazzaro F; Weïwer M; Zhang YL; Holson EB J Med Chem; 2013 Jun; 56(11):4816-20. PubMed ID: 23672185 [TBL] [Abstract][Full Text] [Related]
58. A cyclodextrin-capped histone deacetylase inhibitor. Amin J; Puglisi A; Clarke J; Milton J; Wang M; Paranal RM; Bradner JE; Spencer J Bioorg Med Chem Lett; 2013 Jun; 23(11):3346-8. PubMed ID: 23591111 [TBL] [Abstract][Full Text] [Related]
59. Novel urushiol derivatives as HDAC8 inhibitors: rational design, virtual screening, molecular docking and molecular dynamics studies. Zhou H; Wang C; Deng T; Tao R; Li W J Biomol Struct Dyn; 2018 Jun; 36(8):1966-1978. PubMed ID: 28632421 [TBL] [Abstract][Full Text] [Related]
60. The chemical tuning of a weak zinc binding motif for histone deacetylase using electronic effects. McCarren P; Hall ML; Whitehead L Chem Biol Drug Des; 2012 Aug; 80(2):203-14. PubMed ID: 22429492 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]